Literature DB >> 9458289

Fas antigen expression in hepatocellular carcinoma tissues.

Y Ito1, T Takeda, K Umeshita, M Sakon, K Wakasa, N Matsuura, M Monden.   

Abstract

Fas antigen belongs to the tumor necrosis factor receptor family and is known to induce apoptosis. This protein is abundantly expressed in hepatocytes, especially in acute and chronic hepatitis. To elucidate the clinical significance of Fas in hepatocellular carcinoma (HCC), we investigated its expression in 50 HCC having various characteristics. Fas was comprehensively expressed in non-cancerous hepatocytes as well as bile ducts. It was moderately expressed in histiocytes in the stroma rather than in infiltrating lymphocytes. In HCC, Fas expression was significantly reduced when there was poor differentiation (p<0.001), portal tumor thrombus and extracapsular invasion (p<0.05) according to univariate analysis. Multivariate analysis revealed statistical significance between Fas expression and the degree of differentiation (p=0.0002). These results suggest that HCC, like non-cancerous hepatocytes, express Fas antigen, when they are well or moderately differentiated but lose this ability when they become poorly differentiated as the carcinoma advances.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9458289

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  9 in total

Review 1.  Hepatocyte death: a clear and present danger.

Authors:  Harmeet Malhi; Maria Eugenia Guicciardi; Gregory J Gores
Journal:  Physiol Rev       Date:  2010-07       Impact factor: 37.312

Review 2.  Apoptosis: a mechanism of acute and chronic liver injury.

Authors:  M E Guicciardi; G J Gores
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

3.  Smad3 reduces susceptibility to hepatocarcinoma by sensitizing hepatocytes to apoptosis through downregulation of Bcl-2.

Authors:  Yu-An Yang; Gen-Mu Zhang; Lionel Feigenbaum; Ying E Zhang
Journal:  Cancer Cell       Date:  2006-06       Impact factor: 31.743

4.  Apoptosis and Fas system are significantly involved in the process of liver cirrhosis converting into hepatocellular carcinoma.

Authors:  Z Peng; H Tang; Y Ling; G Han
Journal:  J Tongji Med Univ       Date:  2001

Review 5.  Apoptosis as a mechanism for liver disease progression.

Authors:  Maria Eugenia Guicciardi; Gregory J Gores
Journal:  Semin Liver Dis       Date:  2010-10-19       Impact factor: 6.115

Review 6.  Antitumor immunity produced by the liver Kupffer cells, NK cells, NKT cells, and CD8 CD122 T cells.

Authors:  Shuhji Seki; Hiroyuki Nakashima; Masahiro Nakashima; Manabu Kinoshita
Journal:  Clin Dev Immunol       Date:  2011-11-29

7.  Both cell proliferation and apoptosis significantly predict shortened disease-free survival in hepatocellular carcinoma.

Authors:  Y Ito; N Matsuura; M Sakon; T Takeda; K Umeshita; H Nagano; S Nakamori; K Dono; M Tsujimoto; M Nakahara; K Nakao; M Monden
Journal:  Br J Cancer       Date:  1999-10       Impact factor: 7.640

8.  The status of Fas and Fas ligand expression can predict recurrence of hepatocellular carcinoma.

Authors:  Y Ito; M Monden; T Takeda; H Eguchi; K Umeshita; H Nagano; S Nakamori; K Dono; M Sakon; M Nakamura; M Tsujimoto; M Nakahara; K Nakao; Y Yokosaki; N Matsuura
Journal:  Br J Cancer       Date:  2000-03       Impact factor: 7.640

9.  Disruption of the FasL/Fas axis protects against inflammation-derived tumorigenesis in chronic liver disease.

Authors:  Francisco Javier Cubero; Marius Maximilian Woitok; Miguel E Zoubek; Alain de Bruin; Maximilian Hatting; Christian Trautwein
Journal:  Cell Death Dis       Date:  2019-02-08       Impact factor: 8.469

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.